Hikma Gilead Vectura The Covid Triangle8 Aug 2020 12:20
In addition, Hikma said it has started manufacturing Covid-19 treatment remdesivir, from Foster City, California-based Gilead Sciences at Gilead's Portugal facility, for an undisclosed amount.
Hikma will supply the first batches of the antiviral drug, and Gilead is expected to distribute the treatment, which was the first to be approved to treat symptoms caused by the coronavirus that causes Covid-19.